Does dapagliflozin affect the metabolic response in patients with elevated alanine aminotransferase and Type 2 diabetes? The Association of British Clinical Diabetologists (ABCD) nationwide dapagliflozin audit

被引：0
|
作者：
Yadagiri, M. [1 ]
Sen Gupta, P. [1 ]
Stephens, J. W. [2 ]
Robinson, A. [3 ]
Phylactou, M. [4 ]
Kennedy, A. [5 ]
Clark, J. [6 ]
Wilding, J. [7 ]
Adamson, K. A. [8 ]
Ryder, R. E. J. [1 ]
机构：
[1] Sandwell & West Birmingham Hosp NHS Trust, Dept Diabet, Birmingham, W Midlands, England
[2] Abertawe Bro Morgannwg Univ NHS Trust, Dept Diabet, Swansea, W Glam, Wales
[3] Royal United Hosp Bath NHS Trust, Dept Diabet, Bath, Avon, England
[4] Queen Elizabeth II Hosp, Dept Diabet, Welwyn Garden City, Herts, England
[5] Northern Trust, Antrim Area Hosp, Dept Diabet, Coleraine, Antrim, North Ireland
[6] Surrey & Sussex Healthcare NHS Trust, Dept Diabet, Redhill, Surrey, England
[7] Aintree Univ Hosp NHS Fdn Trust, Dept Diabet, Liverpool, Merseyside, England
[8] West Lothian NHS Trust, Dept Diabet, Livingston, Scotland
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A73
引用
收藏
页码：30 / 31
页数：3
相关论文
共 41 条
  • [1] Does Dapagliflozin Affect the Metabolic Response in Patients with Elevated Alanine Aminotransferase (ALT) and Type 2 Diabetes? The Association of British Clinical Diabetologists Nationwide Dapagliflozin Audit
    Yadagiri, Mahender
    Sen Gupta, Piya
    Cull, Melissa L.
    Price, David
    Oguntolu, Victor
    Imtiaz, Komal
    Barnes, Denis
    Nugent, Ailish
    Robinson, Anthony
    Gallen, Ian W.
    Adamson, Karen A.
    Ryder, Robert E. J.
    DIABETES, 2016, 65 : A293 - A294
  • [2] Does liraglutide therapy affect the metabolic response in patients with elevated alanine aminotransferase and Type 2 diabetes?: the Association of British Clinical Diabetologists (ABCD) nationwide liraglutide audit
    Sen Gupta, P.
    Thong, K. Y.
    Cull, M.
    Winocour, P.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2013, 30 : 3 - 3
  • [3] Dapagliflozin in Renal Impairment: The Association of British Clinical Diabetologists Nationwide Dapagliflozin Audit
    Yadagiri, Mahender
    Bain, Stephen C.
    Robinson, Tony
    Wilding, John P. H.
    Pang, Terence
    Mcgowan, Barbara
    Winocour, Peter
    Oguntolu, Victor
    Clark, James
    Partridge, Helen
    Gallen, Ian W.
    Adamson, Karen
    Ryder, Robert E. J.
    DIABETES, 2017, 66 : A45 - A45
  • [4] The Glycemic Response to Dapagliflozin According to Intensity of Background Diabetes Treatment or Duration of Type 2 Diabetes: The Association of British Clinical Diabetologists Nationwide Dapagliflozin Audit
    Thong, Ken Y.
    Yadagiri, Mahender
    Sen Gupta, Piya
    Winocour, Peter
    Joshi, Mamta
    Wilding, John
    Stephens, Jeffrey W.
    Bain, Stephen C.
    Robinson, Anthony
    Gallen, Ian W.
    Adamson, Karen
    Ryder, Robert E. J.
    DIABETES, 2016, 65 : A307 - A307
  • [5] Does Liraglutide Therapy Affect the Metabolic Response in Patients With Elevated Alanine Aminotransferase and Type 2 Diabetes Mellitus?: The ABCD Nationwide Liraglutide Audit
    Sen Gupta, Piya
    Thong, Ken Y.
    Armstrong, Matthew
    Newsome, Philip N.
    Winocour, Peter
    Ryder, Rej
    DIABETES, 2013, 62 : A267 - A267
  • [6] The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme
    Crabtree, Thomas S. J.
    Phillips, Suzanne M.
    Evans, Alison
    Sennik, Devesh K.
    Rohilla, Anurita
    Bickerton, Alex
    Darzy, Ken H.
    Winocour, Peter
    Cull, Melissa L.
    Strzelecka, Anna
    Raghavan, Rajeev P.
    Gallen, Ian W.
    Yadagiri, Mahender
    Ryder, Robert E.
    DIABETES, 2020, 69
  • [7] The Effect of Semaglutide on Alanine Aminotransferase (ALT) Levels: Results from the Association of British Clinical Diabetologists (ABCD) Audit
    Crabtree, Thomas S. J.
    Sennik, Devesh K.
    Bickerton, Alex
    Barnes, Dennis
    Sivappriyan, Siva
    Adamson, Karen
    Phillips, Suzanne M.
    Evans, Alison
    Larsen, Niels
    Panesar, Avinash
    Cull, Melissa L.
    Gallen, Ian W.
    Idris, Iskandar R.
    Ryder, Robert E.
    DIABETES, 2022, 71
  • [8] HbA1c, Weight, Body Mass Index (BMI), and Systolic Blood Pressure Response to Dapagliflozin: The Association of British Clinical Diabetologists Nationwide Dapagliflozin Audit
    Yadagiri, Mahender
    Sen Gupta, Piya
    Kennedy, Adele
    Pang, Terence
    Clark, James
    Pathan, Hafsa
    Johnston, Phillip C.
    Chudleigh, Richard
    Robinson, Anthony
    Gallen, Ian W.
    Adamson, Karen A.
    Ryder, Robert E. J.
    DIABETES, 2016, 65 : A305 - A306
  • [9] The Association between Empagliflozin and Changes in Alanine Aminotransferase Levels: Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme
    Crabtree, Thomas S. J.
    Elliott, Jackie
    Bickerton, Alex
    Gallen, Ian W.
    Dhatariya, Ketan
    Cull, Melissa L.
    Evans, Alison
    Phillips, Suzanne M.
    Ryder, Robert E.
    DIABETES, 2021, 70
  • [10] Relationship between Canagliflozin Treatment Response and Duration of Diabetes: The Association of British Clinical Diabetologists (ABCD) Nationwide Canagliflozin Audit
    Ryder, Robert E. J.
    Phillips, Suzanne M.
    Evans, Alison
    Sennik, Devesh K.
    Rohilla, Anurita
    Bickerton, Alex
    Thong, Ken
    Yadagiri, Mahender
    Cull, Melissa L.
    Wyres, Melanie C.
    Winocour, Peter
    Darzy, Ken H.
    Strzelecka, Anna
    Gohil, Shailesh G.
    Gallagher, Alison
    Gallen, Ian W.
    DIABETES, 2019, 68
12345